title: Anti-aβ oligomer IgG and surface sialic acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment.
abstract: The fraction of IgG antibodies with anti-oligomeric Aβ affinity and surface sialic acid was compared between Octagam and Gammagard intravenous immunoglobulin (IVIG) using two complementary surface plasmon resonance methods. These comparisons were performed to identify if an elevated fraction existed in Gammagard, which reported small putative benefits in a recent Phase III clinical trial for Alzheimer's Disease. The fraction of anti-oligomeric Aβ IgG was found to be higher in Octagam, for which no cognitive benefits were reported. The fraction and location of surface-accessible sialic acid in the Fab domain was found to be similar between Gammagard and Octagam. These findings indicate that anti-oligomeric Aβ IgG and total surface sialic acid alone cannot account for reported clinical differences in the two IVIG products. A combined analysis of sialic acid in anti-oligomeric Aβ IgG did reveal a notable finding that this subgroup exhibited a high degree of surface sialic acid lacking the conventional α2,6 linkage. These results demonstrate that the IVIG antibodies used to engage oligomeric Aβ in both Gammagard and Octagam clinical trials did not possess α2,6-linked surface sialic acid at the time of administration. Anti-oligomeric Aβ IgG with α2,6 linkages remains untested as an AD treatment.
authors.affiliation: Department of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America.
authors.forename: Hyewon
authors.initials: H
authors.lastname: Kwon
authors.affiliation: Division of Science and Mathematics, University of Washington, Tacoma, Washington, United States of America.
authors.forename: Amanda C
authors.initials: AC
authors.lastname: Crisostomo
authors.affiliation: Division of Science and Mathematics, University of Washington, Tacoma, Washington, United States of America.
authors.forename: Hayley Marie
authors.initials: HM
authors.lastname: Smalls
authors.affiliation: Division of Science and Mathematics, University of Washington, Tacoma, Washington, United States of America.
authors.forename: John M
authors.initials: JM
authors.lastname: Finke
mesh_terms: D000544:Alzheimer Disease / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000276:immunology*; D001704:Biopolymers; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis* / Q000276:immunology; D016756:Immunoglobulins, Intravenous / Q000737:chemistry*; D019158:N-Acetylneuraminic Acid / Q000032:analysis*; D020349:Surface Plasmon Resonance; D016896:Treatment Outcome
chemical_list: D016229:Amyloid beta-Peptides; D001704:Biopolymers; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D019158:N-Acetylneuraminic Acid
references.citation: J Biol Chem. 2003 Nov 28;278(48):48245-50
references.pmid: 14500706
references.citation: BMC Microbiol. 2008;8:3
references.pmid: 18182097
references.citation: Science. 2006 Aug 4;313(5787):670-3
references.pmid: 16888140
references.citation: Ann Neurol. 1999 Dec;46(6):860-6
references.pmid: 10589538
references.citation: Anal Biochem. 1985 Feb 15;145(1):27-36
references.pmid: 3923863
references.citation: J Immunol Methods. 2012 Aug 31;382(1-2):167-76
references.pmid: 22683540
references.citation: J Biol Chem. 1996 Aug 23;271(34):20631-5
references.pmid: 8702810
references.citation: J Neurochem. 2007 Jun;101(5):1172-84
references.pmid: 17286590
references.citation: J Neurosci Res. 1998 Nov 15;54(4):522-9
references.pmid: 9822162
references.citation: Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9868-72
references.pmid: 23697368
references.citation: Lancet Neurol. 2013 Mar;12(3):233-43
references.pmid: 23375965
references.citation: PLoS One. 2012;7(6):e39565
references.pmid: 22761827
references.citation: PLoS One. 2012;7(4):e36261
references.pmid: 22558410
references.citation: J Neuroimmunol. 2010 Oct 8;227(1-2):167-74
references.pmid: 20638733
references.citation: J Neurosci Methods. 2010 Mar 30;187(2):263-9
references.pmid: 20097229
references.citation: Lancet. 1993 Oct 16;342(8877):945-9
references.pmid: 8105212
references.citation: J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1472-4
references.pmid: 15377700
references.citation: J Mol Recognit. 2014 Jan;27(1):46-56
references.pmid: 24375583
references.citation: Nat Neurosci. 2012 Mar;15(3):349-57
references.pmid: 22286176
references.citation: Biochem Soc Trans. 2005 Nov;33(Pt 5):1087-90
references.pmid: 16246051
references.citation: Anal Biochem. 1997 Jul 1;249(2):153-64
references.pmid: 9212867
references.citation: J Biol Chem. 2009 Feb 13;284(7):4230-7
references.pmid: 19098006
references.citation: J Alzheimers Dis. 2010;21(1):1-14
references.pmid: 20182045
references.citation: J Immunol Methods. 1997 Feb 14;201(1):25-34
references.pmid: 9032407
references.citation: Proteomics. 2008 Jul;8(14):2858-71
references.pmid: 18655055
references.citation: Nat Med. 2000 Aug;6(8):916-9
references.pmid: 10932230
references.citation: J Immunol. 1984 Mar;132(3):1386-96
references.pmid: 6693769
references.citation: N Engl J Med. 2014 Jan 23;370(4):311-21
references.pmid: 24450890
references.citation: Methods Enzymol. 1999;309:189-204
references.pmid: 10507025
references.citation: Anal Biochem. 1997 Jul 1;249(2):165-73
references.pmid: 9212868
references.citation: PLoS One. 2013;8(12):e81448
references.pmid: 24324693
references.citation: Neurobiol Aging. 2009 Nov;30(11):1728-36
references.pmid: 18294736
references.citation: J Neurosci. 2006 May 31;26(22):6011-8
references.pmid: 16738244
references.citation: Autoimmun Rev. 2008 Jun;7(6):415-20
references.pmid: 18558354
references.citation: Proc Natl Acad Sci U S A. 2003 May 27;100(11):6370-5
references.pmid: 12750461
references.citation: J Neuroinflammation. 2013;10:70
references.pmid: 23735288
references.citation: Biochemistry. 2009 Mar 10;48(9):1870-7
references.pmid: 19216516
references.citation: Glycoconj J. 2007 Dec;24(9):591-604
references.pmid: 17805962
references.citation: J Biol Chem. 2003 Mar 28;278(13):11612-22
references.pmid: 12499373
references.citation: J Clin Immunol. 2010 May;30 Suppl 1:S37-42
references.pmid: 20405179
references.citation: Anal Biochem. 1989 Nov 1;182(2):319-26
references.pmid: 2610349
references.citation: Anal Chem. 2008 Jun 1;80(11):4007-13
references.pmid: 18461973
references.citation: Science. 2008 Apr 18;320(5874):373-6
references.pmid: 18420934
references.citation: Biochemistry. 2008 Nov 25;47(47):12254-6
references.pmid: 18956886
references.citation: J Neurosci. 2011 Apr 13;31(15):5847-54
references.pmid: 21490226
references.citation: J Exp Med. 2007 Jan 22;204(1):11-5
references.pmid: 17227911
references.citation: Neuron. 2014 Jan 8;81(1):49-60
references.pmid: 24411731
references.citation: N Engl J Med. 2014 Jan 23;370(4):322-33
references.pmid: 24450891
references.citation: PLoS One. 2013;8(11):e80501
references.pmid: 24223227
references.citation: Immunol Lett. 2013 Jul-Aug;154(1-2):7-11
references.pmid: 23928186
references.citation: Biochemistry. 2002 Jul 2;41(26):8263-76
references.pmid: 12081475
references.citation: Proteomics. 2009 Sep;9(17):4143-53
references.pmid: 19688751
references.citation: Annu Rev Public Health. 2002;23:213-31
references.pmid: 11910061
references.citation: PLoS One. 2011;6(6):e21246
references.pmid: 21731683
references.citation: Mol Neurodegener. 2013;8:36
references.pmid: 24148220
references.citation: J Alzheimers Dis. 2010;20(1):135-43
references.pmid: 20164596
references.citation: Biochemistry. 2003 Nov 11;42(44):12749-60
references.pmid: 14596589
references.citation: Neurosci Lett. 2009 Jan 16;449(3):240-5
references.pmid: 18786612
references.citation: Glycobiology. 2009 Sep;19(9):958-70
references.pmid: 19318519
references.citation: Nat Rev Neurol. 2011 Jun 21;7(7):359
references.pmid: 21691336
references.citation: Int Immunopharmacol. 2010 Jan;10(1):115-9
references.pmid: 19840873
references.citation: Ann Neurol. 2002 Aug;52(2):253-6
references.pmid: 12210803
references.citation: PLoS One. 2012;7(6):e37243
references.pmid: 22675478
references.citation: Clin Neuropharmacol. 2010 Mar-Apr;33(2):67-73
references.pmid: 20375655